Home Sectors Healthcare Latest Movement: Emergent Biosolutions (NYSE: EBS)

Latest Movement: Emergent Biosolutions (NYSE: EBS)


Emergent Biosolutions is part of the biotechnology industry and is in the healthcare sector. The company CEO is Daniel J. Abdun-Nabi. Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.

Previous Intraday Trading Performance:

The EBS stock showed a previous change of -6.27% with an open at 72.75 and a close of 68.65. It reached an intraday high of 73.88 and a low of 67.91.

SeekingAlpha:  Altimmune: Suppressed, Immature, Or Dormant?


The stock has a market cap of $3.5b with 50.9m shares outstanding, of which the float is 48.6m shares. Trading volume reached 616,667 shares compared to its average volume of 389,919 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Emergent Biosolutions shares returned -5.10% and in the past 30 trading days it returned 13.47%. Over three months, it changed 14.84%. In one year it has changed 62.06% and within that year its 52-week high was 73.89 and its 52-week low was 41.59. EBS stock is 65.06% above its 52 Week Low.

Our calculations show a 200 day moving average of 56.99 and a 50 day moving average of 65.57. Currently EBS stock is trading 20.46% above its 200 day moving average.

SeekingAlpha:  Altimmune: Suppressed, Immature, Or Dormant?


The last annual fiscal EPS for the company was reported at 1.7 that ended on 31st of December 2017, which according to the previous close, that is a PE of 40.38. Based on 3 analyst estimates, the consensus EPS for the next quarter is 0.62. The TTM EPS is 2.33, which comes to a TTM PE of 29.46. Historically, the PE high was 50.90 and the PE low was 17.00. If the stock reached its PE low, that would represent a price of 39.61, which is a decrease of -42.29%.

The following are the last four quarter reported earnings per share:
09-30-2018:  0.55
06-30-2018:  1.07
03-31-2018:  -0.03
12-31-2017:  0.74

Base on our calculations, the intrinsic value per share is 67.87, which means it may be overvalued by -1.14%

Indicators to Watch:

Based on the latest filings, there is 127.50% of institutional ownership. Short-interest is 2,241,783, which is 4.40% of shares outstanding. The short-interest ratio or days-to-cover ratio is 6.37. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 1.30

SeekingAlpha:  Echo Global Logistics (ECHO) Q3 2018 Results – Earnings Call Transcript

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 12.33%, return on assets is 9.15%, profit margin is 14.18%, price-to-sales is 5.29 and price-to-book is 3.62.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 3  :Past Performance Score
 6  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.